A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2

Orith Waisbourd-Zinman1, Lea F Surrey2, Anna E Schwartz1

  • 1Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Annals of Hepatology
|April 21, 2017
PubMed

Insights

Two siblings with a mild form of Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) showed a favorable outcome. This case highlights novel ABCB11 gene variants associated with a less severe PFIC2 presentation.

Area of Science:

  • Hepatology
  • Genetics
  • Rare Diseases

Background:

  • Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) is a severe genetic liver disease.
  • Mutations in the ABCB11 gene impair bile salt export, leading to liver damage.
  • Current treatments have variable success, often necessitating liver transplantation.

Observation:

  • Two siblings presented with mild PFIC2 symptoms in infancy, including cholestasis and vitamin deficiencies.
  • Both siblings recovered and remained asymptomatic after infancy.
  • Genetic analysis revealed compound heterozygosity for two novel ABCB11 missense mutations: p.C68Y and p.R832H.

Findings:

  • The identified ABCB11 variants (p.C68Y and p.R832H) are associated with an unusually mild PFIC2 phenotype.
  • These patients did not require standard PFIC2 medical interventions.
  • This is the first report detailing these specific variants in a mild PFIC2 presentation.

Implications:

  • These findings expand the understanding of genotype-phenotype correlations in PFIC2.
  • Novel ABCB11 variants may represent a milder spectrum of the disease.
  • Further research into these variants could inform personalized treatment strategies for PFIC2.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
963
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
954
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.4K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
440
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
42